US-based biologics manufacturer Bionova Scientific, a subsidiary of Japanese chemical company Asahi Kasei Corp, has unveiled a new facility in Fremont, California, US.
Spanning 5109sqm, Bionova Scientific’s new process development and pilot plant will expand its ability to advance early-stage biologics assets to first-in-human trials. Additionally, it will also facilitate the future expansion of its manufacturing capacity.
Go deeper with GlobalData
Darren Head, chairman & president of Bionova, said, “Many of our customers are early-stage biopharmaceutical innovators who need agile partners providing quick process development and reliable manufacturing operations.”
“This new facility enhances our capacity to serve early-stage clients while also providing overflow capacity for our larger biopharma customers,” he added.
Fremont Mayor Raj Salwan congratulated Bionova for its new facility and was optimistic about their continued partnership in the future.
Dubbed Biotech Bay, the San Francisco Bay Area is home to one of the largest biotech clusters, with over 250 biotech companies.
Michelle Chen, senior vice president for process development and manufacturing at Bionova, commented, “With this new facility, all of our pre-GMP activities are co-located and integrated under one roof.”
This adds to Bionova’s investments in the US. Last year, in June 2024, it opened a new production plant in Woodlands, Texas.
